• SENSEX 81,099.94
    -351.07 (--0.43%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Niva Bupa Health
    82.00 61.01(%)
  • Reliance Power
    62.80 60.50(%)
  • Max Healthcare
    1,156.00 1,227.50(%)
  • Mazagon Dock
    3,380.35 1,200.00(%)
  • Garden Reach Sh.
    2,875.00 1,148.10(%)
  • Suzlon Energy
    73.44 86.04(%)
  • Yes Bank
    22.86 27.41(%)
  • St Bk of India
    818.50 912.10(%)
  • Reliance Infra.
    346.80 350.90(%)
  • Inox Wind
    190.30 124.35(%)
  • Eternal Ltd
    243.00 304.50(%)
  • Cochin Shipyard
    1,900.55 1,180.45(%)
  • SG Finserve
    445.95 546.00(%)
  • Bharat Dynamics
    1,965.00 897.15(%)
  • Bank of Maha
    57.80 73.50(%)
  • Data Pattern
    2,972.00 3,654.75(%)
  • MMTC
    77.42 42.55(%)
  • TD Power Systems
    510.05 282.00(%)
  • NBCC
    127.25 139.83(%)
  • Canara Bank
    116.80 129.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Adline Chem Lab Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5655.0
  • ISIN : INE276T01018
14.61 0 (0.41%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    14.61

  • Today’s High

    14.84

  • Open

    14.80

  • Perv Close

    14.55

  • 52W Low

    9.40

  • 52W High

    26.01

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    8.55

  • Div & Yield %

    0.00

  • Book Value(₹)

    -2.55

  • Debt-Equity Ratio

    0.41

  • AGM Date

    30-May-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    8.55

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.85

  • BV (₹)

    -2.50

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -0.13

  • NP Var(%)

    10.0

  • Div%

    0.0

  • CPS (₹)

    -0.20

  • EPS (₹)

    -0.20

  • Traded Value (₹ in Lakhs)

    8.55

  • 52 Week High

    26.01

  • 52 Week Low

    9.40

  • Price BSE

    15.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    8.55

  • P/C Ratio

    -66.40

  • P/E Ratio

    -66.40

  • Price Vs.BV

    -0.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.74 6.33 6.59 5.59
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.74 6.33 6.59 5.59
Other Income 0.03 1.00 1.33 0.00 8.21 0.25
Stock Adjustments 0.00 -0.26 -0.13 -0.70 -1.63 1.04
Total Income 0.03 0.74 1.94 5.63 13.17 6.88
EXPENDITURE :            
Raw Materials 0.00 0.00 0.35 2.33 3.25 2.46
Power and Fuel Cost 0.00 0.00 0.01 0.03 0.07 0.12
Employee Cost 0.04 0.05 0.18 1.71 1.94 1.52
Other Manufacturing Expenses 0.00 0.00 0.00 0.10 0.34 0.05
Selling and Administration Expenses 0.13 0.07 0.23 1.08 1.19 0.90
Miscellaneous Expenses 0.01 4.76 0.12 0.60 9.44 0.99
Employee Benefit Expenses 0.04 0.05 0.18 1.71 1.94 1.52
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.18 4.88 0.90 5.86 16.24 6.04
Operating Profit -0.15 -4.15 1.03 -0.23 -3.06 0.83
Interest 0.00 0.00 0.01 0.03 0.02 0.07
Gross Profit -0.15 -4.15 1.02 -0.26 -3.08 0.76
Depreciation 0.00 0.09 0.35 1.02 0.42 0.73
Profit Before Tax -0.15 -4.24 0.67 -1.28 -3.50 0.03
Current Tax 0.00 0.00 0.00 0.00 0.26 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 -0.05 0.00 0.00 0.00
Reported Net Profit -0.15 -4.23 0.72 -1.28 -3.76 0.03
Extraordinary Items 0.00 -4.35 1.14 0.00 0.22 0.01
Adjusted Net Profit -0.15 0.12 -0.42 -1.28 -3.98 0.02
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -7.62 -3.38 -4.10 -2.82 0.95 0.92
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -7.76 -7.62 -3.38 -4.10 -2.82 0.95
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.25 -7.24 1.23 -2.19 -6.44 0.05
Earnings Per Share(Adj)-Unit Curr - -7.24 1.23 -2.19 -6.44 0.05
Book Value -2.93 -2.68 4.53 3.30 5.49 11.93
Book Value(Adj)-Unit Curr - -2.68 4.53 3.30 5.49 11.93

Shareholding Pattern

  • Promoter Group

    29.61%

  • Public Share Holding

    70.39%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,732,240 29.61 1,512,440 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,732,240 29.61 1,512,440 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 15,500 0.27 12,300 13
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 578,450 9.89 9,950 950
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 252,600 4.32 22,900 5
Individuals holding nominal share capital up to Rs. 1 lakh 3,265,010 55.81 284,800 17,530
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 6,200 0.11 6,200 7
Sub Total 4,117,760 70.39 336,150 18,505
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,850,000 100.00 1,848,590 18,514

Company Background

Adline Chem Lab LtdPharmaceuticals - Indian - Formulations

  • Adline Chem Lab Ltd
  • BSE Code : 5655.0
  • ISIN : INE276T01018

  • Incorporation Year

    1988

  • Registered Office

    904 9th Floor
    Shapath-I Complex S G Highway, Ahmedabad,
    Gujarat-382721

  • Telephone

    91-02764-286549/286559

  • FAX

    91-02764-286038

  • Chairman

  • Managing Director

    SARANG PATHAK

  • Company Secretary

  • Auditor

    Deepak Soni & Associates/Jain Kedia & Sharma

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-1 Off C.G Road ,Ellisbridge
    Mumbai - Ahmedabad-380006

Adline Chem Lab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Adline Chem Lab 14.61 0.03 0.00 -63.52 0.00
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92